Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Day One Biopharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
DAWN
Nasdaq
8731
https://dayonebio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Day One Biopharmaceuticals Inc
Companies Like Day One Biopharmaceuticals (NASDAQ:DAWN) Are In A Position To Invest In Growth
- Mar 15th, 2024 3:30 pm
13 Best Biotech Stocks To Buy Under $20
- Mar 13th, 2024 11:07 am
Day One Biopharmaceuticals Inc (DAWN) Reports Q4 and Full Year 2023 Financial Results
- Feb 28th, 2024 9:32 am
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
- Feb 26th, 2024 9:30 pm
Dwayne 'The Rock' Johnson's net worth: How the new TKO Board Member built his wealth from $7
- Jan 31st, 2024 10:12 pm
Day One Announces Two New Appointments to Board of Directors
- Jan 17th, 2024 1:00 pm
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 19th, 2023 1:00 pm
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
- Nov 17th, 2023 12:00 pm
Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference
- Nov 14th, 2023 1:00 pm
Day One Biopharmaceuticals Inc (DAWN) Reports Q3 2023 Financial Results and Corporate Progress
- Nov 6th, 2023 10:16 pm
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
- Nov 6th, 2023 9:30 pm
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
- Nov 4th, 2023 4:16 pm
Apple’s Journal app has arrived – here’s what’s good and bad
- Oct 30th, 2023 11:27 pm
Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
- Oct 30th, 2023 12:00 pm
We're Hopeful That Day One Biopharmaceuticals (NASDAQ:DAWN) Will Use Its Cash Wisely
- Oct 7th, 2023 2:55 pm
25 Biggest Stocks with Negative Beta
- Sep 29th, 2023 4:43 pm
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
- Sep 12th, 2023 1:02 am
Jeff Bezos Used These Strategies for Business Success: Here’s Why They Work
- Aug 18th, 2023 12:00 pm
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
- Aug 16th, 2023 12:00 pm
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
- Aug 7th, 2023 8:30 pm
Scroll